Therefore, the Zacks rating upgrade for Inspire basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in ...

BofA upgrades Inspire Medical to Buy, setting a $255 price target. The company aims for $950 million in 2025 revenue, with a focus on new product launches and expansion. Shopify Posts Upbeat ...

Inspire Advisors LLC now owns 36,935 shares of the company’s stock valued at $1,112,000 after buying an additional 6,678 shares during the last quarter. The Inspire Faithward Mid Cap Momentum ...